Home/Filings/4/0000950170-24-023532
4//SEC Filing

Bergwerk Dov 4

Accession 0000950170-24-023532

CIK 0000818686other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 6:57 AM ET

Size

7.2 KB

Accession

0000950170-24-023532

Insider Transaction Report

Form 4
Period: 2024-02-28
Bergwerk Dov
Acting Chief Legal Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2024-02-28+6,65396,983 total
  • Exercise/Conversion

    Restricted Share Units

    2024-02-286,6530 total
    Ordinary Shares (6,653 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on February 28, 2020, with 6,653 vesting on February 28, 2024.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001997381

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 6:57 AM ET
Size
7.2 KB